The way in which patients and doctors make healthcare decisions — from choosing therapies to evaluating possible side-effects — is changing rapidly based on newly available genetic testing and analysis. Involution client GeneInsight, a subsidiary of Partners HealthCare is on the forefront of this revolution in personalized medicine.

Last week, Partners HealthCare was featured in a Boston Globe article detailing its ground-breaking technology in whole genome sequencing. The innovative work in this space is being done by Partners HealthCare Center for Personalized Genetic Medicine (PCPGM), which is dedicated to making people’s lives healthier and better by transforming the practice of medicine through increased personalization — based on the accelerated integration of genetic knowledge into clinical care.